Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hyperlipidemias × lorlatinib × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Sexual Dysfunction, Physiological 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Lung Diseases 1 Hyperlipidemias 1 Eunuchism 1 Erectile Dysfunction 1 Brain Neoplasms 1 ALK-positive Non-small Cell Lung Cancer 1 ALK-positive NSCLC 1

Interventions

lorlatinib 1 Urine Specimen Collection 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876675 2025-03-14

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

Peking University Third Hospital

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡